Stazol Depot 50mg/ml 10x1ml Ampullen by Raw Pharma

Usage

1. Review your HGH schedule first.: Map out the days and times you will administer HGH for the full cycle duration, then slot stanozolol injection days to coincide — this reduces the total number of daily interventions and keeps the protocol manageable.
2. Draw Stazol Depot immediately before injection.: Score and snap the glass ampoule using the provided ampoule opener or a sterile gauze wrap; draw the full or partial volume into a fresh 1 ml syringe with a 25–27 gauge needle appropriate for intramuscular delivery.
3. Select an intramuscular injection site.: Gluteal, vastus lateralis, or deltoid are standard sites for aqueous stanozolol; rotate sites across the week if co-administering HGH subcutaneously at the same session to avoid localised tissue stress.
4. Administer slowly and steadily.: Aqueous suspensions can cause injection-site discomfort if delivered too rapidly — a controlled 30-second push reduces post-injection inflammation at the depot site.
5. Log every administration event.: Record ampoule lot number, injection site, dose volume, and any HGH unit administered at the same session; this log supports meaningful lipid and liver enzyme monitoring at weeks four and six.
6. Dispose of the ampoule immediately after use.: Single-dose ampoules are not re-enterable; place the spent glass ampoule and needle in a sharps container and do not attempt to store or re-use partial draws.

Warnings

Frequently asked questions

Can injectable stanozolol 50mg/ml be combined with Human Growth Hormone in the same cycle?

Yes — stanozolol and HGH are mechanistically complementary. Stanozolol activates the androgen receptor and suppresses SHBG within the first one to two weeks, while HGH elevates IGF-1 through hepatic signalling over a six-to-twelve-week timeframe. Running both compounds together covers the early androgenic phase that HGH cannot address on its own timeline, making the pairing a logical choice for body-recomposition cycles.

What specific synergies does a stanozolol and HGH combination offer compared to using either compound alone?

The two compounds operate through entirely separate pathways — androgen receptor activation for stanozolol versus GH receptor and IGF-1 axis signalling for HGH — so their anabolic contributions are additive rather than competitive. Additionally, HGH promotes lipolysis while stanozolol maintains or increases lean mass and nitrogen retention; together they support simultaneous fat reduction and muscle preservation more effectively than either agent used in isolation.

How should an HGH and stanozolol injection stack be planned in terms of timing and weekly structure?

A practical approach is to introduce stanozolol at week one of the HGH cycle, using 25–50 mg every other day, and plan for a six-to-eight-week stanozolol run within a longer HGH protocol of twelve to twenty-four weeks. Injection days can be aligned with HGH administration days to simplify scheduling. Raw Pharma's ten-ampoule pack covers approximately five to six weeks at the every-other-day frequency, fitting neatly into this structure.

Why does Stazol Depot use single-dose 1ml ampoules instead of a multi-dose vial — does it matter for an HGH stack?

Single-dose ampoules eliminate the repeated-entry contamination risk that accumulates with multi-dose vials over a multi-week protocol. When you are already handling reconstituted lyophilised HGH vials requiring careful sterile technique, using a pre-sealed single-dose stanozolol ampoule for each injection reduces one variable in aseptic risk management. Each ampoule is opened, drawn, and discarded — no septum degradation, no cross-contamination pathway.

Is 50mg/ml the right stanozolol concentration for precise low-dose use in an HGH combination cycle?

At 50 mg/ml, a 0.5 ml draw delivers exactly 25 mg — the lower anchor of the evidence-referenced range for HGH combination protocols — using standard 1 ml syringes without approximation. Compared to higher-concentration formulations (100 mg/ml), the 50 mg/ml strength offers finer volume-to-dose resolution at the 25 mg increment, reducing the likelihood of measurement error when titrating conservatively alongside an HGH regimen where the hormonal load is already meaningful. (2) angle_used

Manufacturer

Raw Pharma's single-dose ampoule format for Stazol Depot reflects a deliberate containment philosophy: rather than filling aqueous stanozolol suspension into multi-dose vials — where repeated septum puncture introduces a cumulative contamination risk with each use — the company opts for ten individually sealed 1 ml glass ampoules, each hermetically closed at manufacture and used once. This packaging decision is particularly relevant for aqueous suspensions, which lack the bacteriostatic properties of oil-based vehicles and therefore benefit most from a closed, single-entry presentation. Each ampoule lot is released under a quality chain that requires both reversed-phase HPLC potency verification against the declared 50 mg/ml specification and LAL endotoxin assay clearance; the corresponding batch Certificate of Analysis is signed only when both data sets fall within the approved acceptance criteria. The ampoule format also simplifies dose accountability across a multi-week protocol: ten units, one per injection event, with no need to track residual volume in a shared vial.